From WisPolitics.com/WisBusiness.com …
— COVID-19 activity in Wisconsin has jumped in recent weeks, though not as high as near the end of 2023.
The seven-day average of COVID-19 virus concentration in wastewater treatment centers nearly tripled over the 30-day period ending Dec. 23, the latest date for which figures are available from the Department of Health Services. That total rose from 30.1 million gene copies per person per day on Nov. 23 to 87.8 million at latest count.
But that remains far below the 201.1 million gene copies per person per day seen on Dec. 23, 2023, when the virus was much more prevalent in Wisconsin.
Still, more than half of the wastewater facilities conducting COVID-19 testing in the state had high or very high measurements of the virus, while less than a third had moderate levels and just three sites had low levels, according to the DHS website.
Meanwhile, COVID-19 hospitalizations remain relatively low. The agency’s site shows the seven-day average for hospitalized patients was 198 patients on Dec. 28, compared to 462 patients one year earlier.
— Imbed Biosciences has named Terry Bromley its new CEO, the Middleton-based company announced recently.
Bromley has more than 30 years of experience in the medical device, regenerative medicine, and wound and skin markets. He will lead efforts to transform the future of soft tissue repair through advanced technologies focused on improving patient outcomes, according to the announcement.
“Terry brings a wealth of commercial leadership experience in the wound and skin care sector, delivering innovation and building high-performing teams,” said Imbed Biosciences Founder and Chief Scientific Officer Ankit Agarwal, who previously held the CEO position.
See more at Madison Startups.
Top Stories
– Norovirus outbreaks are on the rise around the country and on cruise ships
– Cruise ship stomach bug illnesses hit 12-year high: CDC
– FDA testing aged raw cow’s milk cheese for bird flu
– Experts Warn of Growing Risks as Bird Flu Cases Rise
– Lilly asks to join lawsuit over compounded versions of its weight-loss drugs
– West Virginia Patients Are Left in Limbo Over Changing Insurance Coverage of Obesity Medications
Press Releases
